Profiel
Tjeerd Barf is the founder of Artica Therapeutics BV, founded in 2020, holding the title of Chief Executive Officer & Executive Director.
Dr. Barf is also the founder of Acerta Pharma BV..
Dr. Barf currently holds the position of Director at Cytura Therapeutics BV since 2019.
Dr. Barf completed graduate and doctorate degrees at the University of Groningen.
Actieve functies van Tjeerd Barf
| Bedrijven | Functie | Begin |
|---|---|---|
Cytura Therapeutics BV
Cytura Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Engages in researching and developing biotechnology | Directeur/Bestuurslid | 01-04-2019 |
Artica Therapeutics BV
Artica Therapeutics BV Pharmaceuticals: MajorHealth Technology Develops covalent therapeutics for autoimmune and inflammatory disorders | Oprichter | 01-01-2020 |
Eerdere bekende functies van Tjeerd Barf
| Bedrijven | Functie | Einde |
|---|---|---|
Acerta Pharma BV
Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Develops drugs for oncology and autoimmune diseases | Oprichter | 01-03-2020 |
Opleiding van Tjeerd Barf
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
University of Groningen
University of Groningen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Acerta Pharma BV
Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Develops drugs for oncology and autoimmune diseases | Health Technology |
Cytura Therapeutics BV
Cytura Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Engages in researching and developing biotechnology | Commercial Services |
Artica Therapeutics BV
Artica Therapeutics BV Pharmaceuticals: MajorHealth Technology Develops covalent therapeutics for autoimmune and inflammatory disorders | Health Technology |
















